Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Laser-Based Bioprinter

Objetivo

Bioprinting is a rapidly developing technology sector aimed at additive manufacturing of tissues and organs. It is expected to lead to the most disruptive biomedical applications of additive manufacturing. Apart from tissue engineering and regenerative medicine, bioprinting applications of immediate commercial and societal benefit include the development of personalized cancer therapies and realization of in vitro tissue models based on human biology for reliable drug tests in pharma industry. The latter one is especially attractive, as it will potentially result in substantial savings of drug development costs. Furthermore, it may help to considerably reduce the need for animal studies in the foreseeable future. The need for increased resolution is one of the main technological challenges of bioprinting today. Most currently available bioprinters are based on dispensing methods. Therefore, the achievable spatial resolution is in the range of tens of micrometers. The possibility to reproduce features on the submicrometer scale would provide the missing link to accessing the complexity of natural cell environment and enable fabrication of truly biomimetic constructs.

Régimen de financiación

ERC-POC - Proof of Concept Grant

Institución de acogida

TECHNISCHE UNIVERSITAET WIEN
Aportación neta de la UEn
€ 149 850,00
Dirección
KARLSPLATZ 13
1040 Wien
Austria

Ver en el mapa

Región
Ostösterreich Wien Wien
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 149 850,00

Beneficiarios (1)